Ahp81632
Lubiprostone Capsule, Gelatin Coated
Product Images NDC 60687-816
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Lubiprostone (NDC 60687-816). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by American Health Packaging, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Ahp82732
8 Mcg Lubiprostone Capsule Blister (Image 01)
This is a description of Lubiprostone capsules. The text mentions that the capsules should not be broken, chewed, or swallowed whole. It also provides some details about the strength and quantity of the capsules. Lubiprostone is typically used for conditions related to the bowels and the digestive system.*
24 Mcg Lubiprostone Capsules Carton (Image 02)
This text contains information about a medication called Lubiprostone in capsule form. The capsules should be swallowed whole and not broken apart or chewed. Each soft gel capsule contains Lubiprostone 24 mcg. The usual dosage details can be found in the full prescribing information. The storage instructions recommend storing the capsules at a temperature between 20 to 25°C. Extreme temperatures should be avoided. The product is distributed by American Health Packaging.*
24 Mcg Lubiprostone Capsule Blister (Image 03)
8 Mcg Lubiprostone Capsules Carton (Image 04)
This text provides information about a medication identified as Lubiprostone capsules with the NDC number 60687-816-32. The capsules should be swallowed whole and not broken apart or chewed. The usual dosage instructions are not provided in the text. It is recommended to store the capsules at a temperature range of 20° to 25°C, with excursions permitted between 15° to 30°C. It is advised to protect the package from extreme temperatures and not to use it if the blister is torn or broken. The drug product contents are indicated to be from NDC 0480-3478 by Teva Pharmaceuticals. The capsules are distributed by American Health Packaging in Columbus, Ohio.*
1 (Image 1)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
